ScholarIQanswers from OpenAlex

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

PaperCitations, authors & open-access status

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease have?

ScholarIQcitation count

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease has 285 citations in the OpenAlex counts ScholarIQ stores.

When was Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease published?

ScholarIQyear

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease has 2001 year in the ScholarIQ index.

What is the open-access status of Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease?

ScholarIQoa status

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease has bronze oa status in the ScholarIQ index.

What is the DOI of Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease?

ScholarIQdoi

The DOI for Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease is on the source record.

What is the PMID of Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease?

ScholarIQpmid

The PMID for Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease is on the source record.

What is the OpenAlex record for Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease?

ScholarIQopenalex

The OpenAlex for Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial